Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas.
Ta VA, Battistella M, Zhao LP, Dobos G, Ram-Wolff C, Madelaine I, Bories JC, Tournilhac O, Rouanet J, Veyrat-Masson R, Bouaziz JD, Marie-Cardine A, Bagot M, Bensussan A, Moins-Teisserenc H, De Masson A. Ta VA, et al. J Invest Dermatol. 2023 Jul;143(7):1329-1332.e3. doi: 10.1016/j.jid.2023.01.009. Epub 2023 Jan 28. J Invest Dermatol. 2023. PMID: 36716922 No abstract available.
CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells.
Moins-Teisserenc H, Daubord M, Clave E, Douay C, Félix J, Marie-Cardine A, Ram-Wolff C, Maki G, Beldjord K, Homyrda L, Michel L, Bensussan A, Toubert A, Bagot M. Moins-Teisserenc H, et al. J Invest Dermatol. 2015 Jan;135(1):247-257. doi: 10.1038/jid.2014.356. Epub 2014 Aug 26. J Invest Dermatol. 2015. PMID: 25158034 Free article.
Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response.
Felix J, Lambert J, Roelens M, Maubec E, Guermouche H, Pages C, Sidina I, Cordeiro DJ, Maki G, Chasset F, Porcher R, Bagot M, Caignard A, Toubert A, Lebbé C, Moins-Teisserenc H. Felix J, et al. Oncoimmunology. 2016 Feb 18;5(7):1136045. doi: 10.1080/2162402X.2015.1136045. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622012 Free PMC article.
Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease.
Hurabielle C, Sicre de Fontbrune F, Moins-Teisserenc H, Robin M, Jachiet M, Coman T, Dhedin N, Cassius C, Chasset F, de Masson A, Michonneau D, Bagot M, Bergeron A, Socié G, Peffault de Latour R, Bouaziz JD. Hurabielle C, et al. Br J Dermatol. 2017 Nov;177(5):e206-e208. doi: 10.1111/bjd.15593. Epub 2017 Oct 22. Br J Dermatol. 2017. PMID: 28422274 No abstract available.
Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity.
Roelens M, Delord M, Ram-Wolff C, Marie-Cardine A, Alberdi A, Maki G, Homyrda L, Bensussan A, Bagot M, Toubert A, Moins-Teisserenc H. Roelens M, et al. Blood. 2017 Sep 21;130(12):1468-1471. doi: 10.1182/blood-2017-03-772996. Epub 2017 Jul 31. Blood. 2017. PMID: 28760889 Free article. No abstract available.
79 results